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Huntington’s disease (HD) is an autosomally domi-
nant neurodegenerative disorder caused by expan-
sion of polyglutamine (polyQ) in the huntingtin (Htt)
protein. Htt yeast two-hybrid protein B (HYPB/
SETD2), a histone methyltransferase, directly inter-
acts with Htt and is involved in HD pathology.
Using NMR techniques, we characterized a poly-
proline (polyP) stretch at the C terminus of HYPB,
which directly interacts with the following WW
domain and leads this domain predominantly to
be in a closed conformational state. The solution
structure shows that the polyP stretch extends
from the back and binds to the WW core domain
in a typical binding mode. This autoinhibitory struc-
ture regulates interaction between the WW domain
of HYPB and the proline-rich region (PRR) of Htt,
as evidenced by NMR and immunofluorescence
techniques. This work provides structural and
mechanistic insights into the intramolecular regula-
tion of the WW domain in Htt-interacting partners
and will be helpful for understanding the pathology
of HD.
INTRODUCTION
Huntington’s disease (HD) is an autosomally dominant neuro-
degenerative disorder caused by the expansion of polyglut-
amine (polyQ) in huntingtin (Htt), a ubiquitously expressed
protein with an as yet unknown function (DiFiglia et al., 1995;
MacDonald et al., 1993). The underlying mechanism leading
to neurodegeneration in HD has not been fully elucidated.
Human Htt is a large protein containing 3,144 residues with
an N-terminal polyQ domain (MacDonald et al., 1993). The
polyQ domain usually contains 35 or fewer residues in unaf-
fected individuals, whereas the number in HD patients extends
to 37 or more glutamine residues (Bates et al., 2002). A proline-
rich region (PRR) containing 40 residues directly follows the
polyQ domain in sequence.
The involvement of PRR in the pathological process of HD can
be observed from the fact that MW7 single-chain variable378 Structure 22, 378–386, March 4, 2014 ª2014 Elsevier Ltd All righfragment, a monoclonal antibody recognizing Htt PRR, signifi-
cantly inhibits the aggregation, as well as the neurotoxicity,
induced by mutant Htt protein (Khoshnan et al., 2002; Southwell
et al., 2008). Many tryptophan (WW) or Src homology 3 (SH3)
domain-containing proteins have been identified that interact
with the PRR of Htt, such as Htt yeast two-hybrid protein
HYPA (also named FBP11) and HYPB (known as SETD2) (Faber
et al., 1998), SH3GL3/endophilin-A3 (Sittler et al., 1998), protein
kinase C and casein kinase substrate in neuron 1 (PACSIN1/
syndapin) (Modregger et al., 2002), and CA150 (Holbert et al.,
2001). Many investigations have revealed that mutant Htt with
expanded polyQ impaired its normal interactions with these
partner proteins. So, it is speculative that HD neuropathology
is related to the interference of the normal function of these pro-
teins by polyQ expansion (Goehler et al., 2004; Harjes and
Wanker, 2003; Landles and Bates, 2004; Li et al., 2003; Li and
Li, 2004).
Human HYPB/SETD2 was previously found by yeast two-
hybrid assay to interact with the N-terminal PRR region of
Htt protein through its WW domain (Faber et al., 1998; Passani
et al., 2000). WW domains are small protein interaction
modules that are found in many eukaryotic proteins (Bork
and Sudol, 1994). The domain folds into a stable, triple-
stranded b sheet structure and interacts with the proteins
with proline-rich or proline-containing motifs (Chen and Sudol,
1995; Kay et al., 2000; Macias et al., 1996). Further studies
have revealed that HYPB, as a histone H3 lysine 36 (H3K36)-
specific methyltransferase, is responsible for virtually all global
and transcription-dependent H3K36 trimethylation throughout
the nucleus (Edmunds et al., 2008; Sun et al., 2005). HYPB
contains a polyproline (polyP) region, which is a potential
WW domain-binding segment. This polyP region is followed
exactly by the WW domain, suggesting a possibility that the
polyP peptide segment interacts with the following WW
domain intramolecularly.
By using nuclear magnetic resonance (NMR) and other tech-
niques in this study, we revealed that the preceding polyP stretch
interacts with the following WW core domain of HYPB to form a
structural entity. This WW-polyP interaction leads to the WW
domain predominantly in a closed conformational state. More-
over, the interaction between the WW domain of HYPB and
PRR of Htt is finely modulated intramolecularly by the polyP
stretch. We propose that this autoinhibitory structure exquisitely
regulates the interaction of HYPB with Htt, which will help us
better understand the pathology of HD.ts reserved
Figure 1. Relationship between the WW Domain and Its Preceding
polyP Stretches of HYPB
(A) Domain architecture of HYPB highlighting the amino acid sequences of the
WW domain and its preceding polyP stretches. The sequence of human
HYPB/SETD2 is based on the database update (RefSeq:NP_054878 and
UniProtKB:Q9BYW2). SET, SET domain; PRR, proline-rich region; PP, poly-
proline; PP1 and PP2, the two polyP stretches; PP12WW, WW domain with
PP12 (PP1 and PP2).
(B) Amino acid sequences of WW and PP2WW from HYPB. The N-terminal
GlySer residues are from the cloning sties. PP2WW, WW domain with PP2.
(C) Overlay of the 1H-15N HSQC spectra of WW (red) and PP12WW (green).
(D) Overlay of the spectra of WW (red) and PP2WW (green). The concentration
for each sample is 500 mM. The chemical shift assignments of the WW
domain are also labeled in the spectra.
See also Table 1 and Figure S1.
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The polyP Stretch of HYPB Interacts with the WW
Domain Intramolecularly
HYPB/SETD2 is a SET domain-containing protein (Wagner and
Carpenter, 2012). It functions as a methyltransferase as its yeast
ortholog Set2p (Sun et al., 2005). Sequence analysis indicates
that HYPB contains a polyP region followed directly by a WW
domain in the C terminus (Figure 1A). The polyP region can be
divided into two peptide segments: PP1 and PP2. To test
whether these peptide segments interact with the following
WW core domain intramolecularly, we constructed three protein
fragments of HYPB: PP12WW, PP2WW, and WW (Figure 1B).
Next, we acquired their 1H-15N heteronuclear single quantum
correlation (HSQC) spectra and performed chemical shift assign-
ments of WW and PP2WW (Figure S1A available online). Com-
parison of the spectra of PP12WW and PP2WW with the WW
spectrum showed that many resonance peaks corresponding
to the residues resided on the typical ligand-binding surface of
the WW domain were significantly perturbed by the polyP region
(Figure 1C), especially by the PP2 segment (Figure 1D). This in-
dicates that the PP2 segment interacts directly with the followingStructure 22,WWdomain intramolecularly. We further characterized the intra-
molecular interaction between PP2 andWW in the PP2WW frag-
ment by conducting a paramagnetic relaxation enhancement
(PRE) experiment (Figure S1B). The peaks of N20, V36, I37,
and T38 in the WW domain were significantly broadened when
S-(2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl meth-
anesulfonothioate was labeled to the N terminus of PP2WW (Fig-
ure S1C). This reconfirms that the ligand-binding surface of the
WW domain in PP2WW is covered by its N-terminal polyP
segment.
The PP2WW Domain Has Two Conformers in Solution
PP2WW is a well-structured domain with intramolecular interac-
tions between the WW core and its preceding polyP stretch.
Interestingly, PP2WW exhibited two sets of resonance peaks,
the major signals and the minor signals, from residues such as
D26, Y34, and Q42 in the 1H-15N HSQC spectrum (Figure 2A),
suggesting that PP2WW has two conformational states in equi-
librium in solution. The pattern of the minor signals in PP2WW
was very similar to that of theWWdomain (Figure 2B). These sig-
nals correspond to the open state, in which the polyP stretch
does not contact the core domain. The major signals are consid-
ered to belong to the closed state, in which the polyP stretch
contacts the core domain to form a structural entity. On the basis
of the peak intensities (heights) in the HSQC spectra, we esti-
mated that approximately an 86% population of PP2WW is in
the closed conformation and a 14% population is in the
open conformation. We prepared two mutants of PP2WW by
substituting 5PSP7 and 9KPK11 to AAA, respectively, in the PP2
region—namely, SPP2WW and KPP2WW—and examined
which residues in the polyP region were responsible for contact-
ing the WW core. As a result, SPP2WW was totally in the
open fraction (Figure 2C), whereas KPP2WW was absolutely
in the closed conformation (Figure 2D). Thus, the 5PSP7 tripep-
tide is important for PP2WW to maintain the closed state,
whereas 9KPK11 is necessary for the open conformation. These
open and closed states were also visualized by fluorescence
emission spectra of these WW domain proteins (Figure S2). As
previously reported in the literature (Jiang et al., 2001; Koepf
et al., 1999), WW and SPP2WW have a maximum emission
wavelength of approximately 352 nm, whereas PP2WW and
KPP2WW have a maximum emission wavelength at 347 nm.
The blue shifts of the fluorescence maximums reflect that the
WW moieties in PP2WW and KPP2WW are covered by the pre-
ceding polyP stretch; that is, both of them are predominantly in
the polyP-bound closed states.
Solution Structure of the PP2WW Domain from HYPB
To understand themechanism underlying the conformational ex-
change of PP2WW in detail, we determined the solution struc-
ture of PP2WW in solution by using NMR techniques. PP2WW
has two conformers in equilibrium, which may give rise to diffi-
culty in structural analysis by NMR techniques. We first per-
formed chemical shift and nuclear Overhauser effect (NOE)
assignments of WWand KPP2WWand determined their solution
structures (Table 1). In general, the WW structure mimics the
open-state structure of PP2WW (Figure S3A), whereas
KPP2WW, similarly to PP2WW, is totally in a closed state (Fig-
ure S3B). On the basis of these two structures, we determined378–386, March 4, 2014 ª2014 Elsevier Ltd All rights reserved 379
Figure 2. PP2WW Has Two Conformational States in Solution
(A) A representative region of the 1H-15N HSQC spectrum of PP2WW. In the spectrum, there are two sets of signals for some residues: onemajor peak represents
the closed state (c), and the minor one indicates the open state (o).
(B) As in (A), the spectrum of WW shows only single peaks.
(C) As in (A), the spectrum of SPP2WW shows only single peaks corresponding to the open state. SPP2WW, a mutant of PP2WW replacing 5PSP7 with AAA.
(D) As in (A), the spectrum of KPP2WW shows only single peaks corresponding to the closed state. KPP2WW, a mutant of PP2WW replacing 9KPK11 with AAA.
See also Figure S2.
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Intramolecular Regulation of HYPBthe solution structure of the closed conformer of PP2WW. The
experimental restraints, structural statistics, and some typical
NOE correlations of PP2WW and other forms are displayed in
Table 1 and Table S1. In the structure, the WW domain moiety
retains a canonical WW fold composed mainly of an antiparallel
b sheet of three strands (Figures 3A and 3B). The N-terminal
polyP segment extends from the back of the ligand-binding sur-
face of theWWdomain and contacts the core domain in a typical
binding mode (Figure 3B). The WW core domain contacts the
polyP peptide chain through the b3 strand and the loop between
b1 and b2 strands. NOE signals were detected between Leu4
and Val36 and between Pro7 and Thr41 (Figure 3C). Abundant
contacts were also observed between the residues in the polyP
segment (Pro7, Pro8, and Ser9) and those in the WW domain
(Trp21, Arg39, Gln40, and hr41).
The structure of the WW domain is very similar to that of
PP2WW in the open state (Figure S3A), whereas the KPP2WW
mutant is absolutely in the closed state without an open-state
fraction (Figure S3B). Structural comparison of PP2WW with
WW suggests that the local structure of the WW core domain
in PP2WW is not influenced considerably by contact with the
polyP segment (Figure S3C). Compared with PP2WW, however,
KPP2WW has an additional short helix in the mutated site (Fig-
ure S3D) due to introduction of three Ala residues that may
enhance a helical formation.380 Structure 22, 378–386, March 4, 2014 ª2014 Elsevier Ltd All righBinding Specificities of the HYPB WW Domain with the
Htt-PRR Portions
HYPB is one of the interacting partners of Htt protein (Faber
et al., 1998), in which the N-terminal PRR motif is proposed to
specifically interact with the WW domain of HYPB. However,
HYPB stays in an autoinhibitory state in most events, whereby
the WW core domain is covered by the preceding polyP stretch.
To elucidate the mechanism by which HYPB interacts with
Htt PRR, we synthesized three peptides corresponding to the
N-terminal (Pept-1), central (Pept-2), and C-terminal (Pept-3)
portions of Htt PRR (Figure 4A) (Gao et al., 2006) and compared
their binding specificities with the WW domain using an NMR
titration method (Figure S4). The data showed that both Pept-1
and Pept-3 interacted with the WW domain of HYPB (Figures
4B, 4C, S4A, and S4C), whereas Pept-2 did not (Figure S4B).
The peptide-binding properties of the WW domain of HYPB
with the Htt PRR peptides are very similar to those of the WW
domain pair of HYPA (Gao et al., 2006; Jiang et al., 2011). For
WW titration with Pept-123, a similar perturbation pattern was
observed in the HSQC spectra of the WW domain (Figure S4D),
except that many peaks became weak or disappeared to some
extent during titration. It suggests that binding of Pept-123 to
WW may undergo conformational changes or intermediate ex-
change at the NMR time scale. The saturation curves for the
chemical shift changes of the five representative residues ints reserved
Table 1. Experimental Restraints and Structural Statistics for the
WW Domain Proteins
Number of
experimental restraints WW (21–43)
PP2WW
(3–43)
KPP2WW
(3–43)
Total unambiguous
distance restraints
439 360 486
Intraresidual 208 186 296
Sequential (j I – j j = 1) 122 103 121
Medium (2% j i – jj% 4) 40 17 18
Long range (j I – jjR 5) 69 54 51
Dihedral angle restraints 52 89 94
Structural statistics
Coordinate precision (A˚)a
Backbone (N, Ca, C’) 0.77 ± 0.21 1.16 ± 0.21 0.76 ± 0.12
Heavy atoms 1.78 ± 0.33 2.39 ± 0.38 1.80 ± 0.22
Backbone, 2nd structure 0.43 ± 0.11 0.55 ± 0.14 0.46 ± 0.13
Heavy atoms,
2nd structure
1.49 ± 0.41 1.62 ± 0.41 1.72 ± 0.29
RMSD from experimental restraints
NOE distances (A˚) 0.09 ± 0.011 0.15 ± 0.02 0.08 ± 0.01
Dihedral angles () 1.96 ± 0.3 3.15 ± 0.30 2.73 ± 0.17
RMSD from idealized geometry
Bonds (A˚) 0.009 ± 0.000 0.007 ± 0.000 0.006 ± 0.000
Angles () 0.92 ± 0.03 0.87 ± 0.04 0.71 ± 0.04
Impropers () 2.44 ± 0.17 2.53 ± 0.1 2.20 ± 0.09
Ramachandran analysis
Residues in most
favored regions
74.2 82.3 86.6
Residues in additionally
allowed regions
20.7 16.3 12.3
Residues in generously
allowed regions
4.32 0.16 0.97
Residues in disallowed
regions
0.81 1.17 0.12
aThe coordinate precision is defined as the average RMS deviation
among the 15 final structures.
Figure 3. NMR Solution Structure of PP2WW from HYPB
(A) Superposition of the backbone traces of the 15 lowest-energy structures.
The backbone trace of residues 3–43 is shown.
(B) Ribbon diagram of a representative structure of PP2WW.
(C) Detailed view of the ribbon diagram of PP2WW. PP2WW is shownwith both
surface and ribbon presentation. The side chains of residues that contact each
other are shown with sticks in the polyP stretch (red) and in the WW domain
(blue). The structures shown were generated with MOLMOL software or the
UCSF Chimera tool.
See also Figure S3.
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Intramolecular Regulation of HYPBtheWWdomain upon titration with Pept-1 and Pept-3 were well-
fitted with 1:1 stoichiometry (Figures 4D and 4E), giving rise to
the dissociation constants (Kd) of about 300 mM for both pep-
tides. This suggests that there is no distinction for the WW
domain of HYPB interacting with the two peptide portions of
Htt PRR.
PP2WW Binds with Htt Pept-1 through Its Open State
PP2WWcontains two conformers in solution, and the molar ratio
of the closed to open state is 6:1. We performed NMR titrations
of PP2WW, SPP2WW, and KPP2WW with Htt Pept-1 (Figure 5).
Intriguingly, with the addition of Pept-1, both peaks for a residue
of PP2WW, such as K30, corresponding to the closed and open
states traced to a single peak corresponding to the bound state
with Pept-1 (Figure 5A). This indicates that Pept-1 directly binds
to the open-state fraction of PP2WW and consequently causes
shifting of the equilibrium from the closed to the open state.
For SPP2WW titrated with Pept-1, the single peak of K30 shifted
to the bound state in a pattern very similar to that of the openStructure 22,state of PP2WW (Figure 5B), whereas for KPP2WW, the peak
shift pattern was like that of the closed state (Figure 5C). The
plots for the chemical shift changes of the peaks from K30
against the concentration of Pept-1 are shown in Figure 5D.
Along the titration curves, we observed that KPP2WW as well
as the closed fraction of PP2WW bound very weakly to Pept-1,
whereas SPP2WW and the open fraction of PP2WW bound
with Pept-1 directly with considerable affinity. By fitting a 1:1
stoichiometry, the Kd value for SPP2WW binding with Pept-1
was calculated to be 250 mM, which is consistent with that for
free WW binding with Pept-1 or Pept-3 (Figure 4). The half-satu-
ration concentration (IC50) of the open fraction of PP2WW was
significantly lower than that of SPP2WW, probably due to the
kinetic limit of the exchange between the closed and open states
in PP2WW. We also observed that the closed state of PP2WW
had a more significant peak shift than KPP2WW, indicating
that an equilibrium shift from the closed to the open fraction
occurred during ligand binding. Collectively, these observations
strongly suggest that the interaction of HYPB with Htt PRR is
finely regulated by intramolecular interaction of the WW domain
with its preceding polyP stretch.378–386, March 4, 2014 ª2014 Elsevier Ltd All rights reserved 381
Figure 4. Three Portions of Htt PRR Have
Different Binding Affinities with the WW
Domain
(A) Sequence of the PRR region from huntingtin
(Htt-PP35). The PRR is divided into three portions:
Pept-1, Pept-2, and Pept-3.
(B and C) Chemical shift perturbations of the
WW domain (100 mM) upon titration with Pept-1
(B) or Pept-3 (C) to a molar ratio of 5:1 (Pept
to WW).
(D and E) Titration curves for Pept-1 (D) or
Pept-3 (E) binding to WW. By fitting the data
to a bimolecular binding algorithm, the dissocia-
tion constant values for Pept-1 and Pept-3
binding to WW are about 300 and 250 mM,
respectively.
See also Figure S4.
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Intramolecular Regulation of HYPBCompetitive Interaction of the WWDomain with Htt PRR
Peptides
To test whether the intramolecular polyP stretch in PP2WW
influences its interaction with Htt PRR, we prepared a GB1
protein fusion of Htt PRR (GB1-PRR) and performed titration382 Structure 22, 378–386, March 4, 2014 ª2014 Elsevier Ltd All rights reservedof the 15N-labeled GB1-PRR peptide
with WW and PP2WW (Figure 6). The
HSQC spectra showed that some reso-
nance peaks of the residues in Htt PRR
were significantly perturbed by WW
domain binding, but PP2WW caused
less effect on the peak intensities
(heights) than WW (Figures 5A and 5B).
Compared with WW, PP2WW exhibited
reduced binding affinity with GB1-PRR(Figure 6C), indicating that the polyP stretch significantly in-
hibited the binding of the WW core domain with Htt PRR. This
suggests that competitive interaction with the WW domain
occurs between intramolecular and intermolecular proline-rich
peptides.Figure 5. Interaction of PP2WW with Htt
Pept-1 in Equilibrium
(A) Traces of the chemical shift changes of a
representative residue (K30) upon titration with
Pept-1. With the addition of Pept-1, both the major
and minor peaks corresponding to the closed (c)
and open (o) states move toward a merged one
corresponding to the bound state (b) of PP2WW
with Pept-1. The concentration of PP2WW is
100 mM.
(B and C) As in (A), traces of the chemical shift
changes (K30) of SPP2WW (B) or KPP2WW (C)
upon titration with Pept-1 are shown.
(D) Titration curves for PP2WW, SPP2WW, and
KPP2WW binding with Pept-1. By fitting the
saturation curve of the chemical shift changes
of SPP2WW against ligand concentration, the
dissociation constant for SPP2WW binding with
Pept-1 is 250 mM.
Figure 6. The polyP Stretch Impedes PP2WW Binding with Htt PRR
(A and B) NMR titration of 15N-labeled GB1-PP35 with WW (A) or PP2WW (B).
The resonance peaks for PP35 are indicated by arrows. The concentration of
GB1-PRR is 100 mM.
(C) Titration curves for two representative peaks, peak 1 (red) and peak 2
(blue), from GB1-PP35 caused by addition of WW (triangle) or PP2WW (circle).
Structure
Intramolecular Regulation of HYPBIntramolecular Interaction in PP2WW Inhibits Its Binding
with Htt in a Cell Model
We next examined whether the interaction between the WW
domain of HYPB and Htt PRRwas affected by the intramolecular
interaction using a cell model (Jiang et al., 2011). We prepared
two constructs of WW and PP2WW from HYPB fused with a
nuclear localization sequence (NLS) (WW-NLS and PP2WW-
NLS) and performed immunofluorescence experiments (Fig-
ure 7). The confocal microscopic imaging showed that, in most
HEK293T cells, the overexpressed WW-NLS and PP2WW-NLS
were localized in the nucleus, whereas the overexpressed
polyQ-expanded Htt (Htt100Q, residues 1–171) was mostly local-
ized in the cytoplasm as reported previously (Jiang et al., 2011).Structure 22,When cotransfected with Htt100Q,WW-NLSwas colocalized with
Htt100Q mostly in the cytoplasm, suggesting that it was seques-
tered to the cytoplasm from the nucleus by interacting with
Htt100Q (Figures 7A and 7C). Under similar conditions, however,
PP2WW-NLS was not sequestered to the cytoplasm by Htt100Q
(Figures 7B and 7C), owing to the inhibitory effect against its
binding with Htt100Q. When removal of PRR from Htt100Q
(Htt100Q-DPRR), the mutant could not sequester WW-NLS or
PP2WW-NLS to the cytoplasm (Figure 7D), indicating that this
sequestration by Htt100Q was dependent on the specific interac-
tion between the WW domain and Htt PRR. Collectively, these
results demonstrate that the intramolecular interaction in
PP2WW significantly inhibits its binding with Htt, by which the
polyP stretch finely regulates the sequestration of HYPB by
Htt100Q in cells.
DISCUSSION
Although both WW domain and proline-rich motif are very small
fractions in a normal functional protein, their diverse interactions
are critically important to transcription and signal transduction
pathways (Neduva and Russell, 2007). These interactions should
be deliberately orchestrated by different cellular factors or regu-
latory modes. Studying the interactions between Htt and its part-
ners based on the small WW domains and PRR motifs are
extremely important to understanding the functional regulation
of Htt and the pathology of HD.
Intramolecular Interactions in Htt-Interacting Partners
HYPB is a single WW domain-containing protein that harbors
several polyP stretches in its entire sequence, suggesting a pos-
sibility that they have intramolecular interactions with the core
WWdomain for structurally allosteric regulation as previously re-
ported in the literature (Cheetham, 2004; Laughlin et al., 2012;
Trudeau et al., 2013). It is likely that the N-terminal polyP region
also plays a role in modulating the interaction of HYPB with Htt
by interactingwith theC-terminalWWdomain, but it may be diffi-
cult for structural and mechanistic analysis. So, we investigated
only the C-terminal polyP stretches preceding the central WW
domain. Our studies demonstrate that the WW domain of
HYPB specifically interacts with the preceding polyP stretch to
form a structural entity and that this autoinhibitory structure pro-
vides an arena for allosterically regulating its interaction with Htt
PRR. This study reports that a polyP stretch acts on autoinhibi-
tion of the nearby core WW domain and allosteric regulation of
its binding to other proline-rich motifs. Analogously, Htt yeast
two-hybrid protein C (HYPC) contains a pair of WW domains
and several polyP regions flanking the domain pair (Faber
et al., 1998; Passani et al., 2000). The novel sequence and struc-
ture are reminiscent of an intramolecular regulation of the WW
domain pair by the polyP stretches for interacting with Htt
PRR. These Htt-interacting partners that putatively have intra-
molecular allosteric regulation deserve further exploration.
Intramolecular Regulation of the WW Domain of HYPB
for Interacting with Htt PRR
In our NMR studies, PP2WW maintained equilibrium between
the closed and open states in solution. The closed state has a
major population (86%), whereas the open state is the minor378–386, March 4, 2014 ª2014 Elsevier Ltd All rights reserved 383
Figure 7. Confocal Fluorescence Microscopy Images Showing Colocalization of Htt100Q with WW or PP2WW in Cells
(A) Colocalization of Htt100Q with WW of HYPB in cytoplasm. Normally, HYPB WW fused with a C-terminal NLS sequence (WW-NLS) localizes in the nucleus,
whereas Htt100Q (residues 1–171) localizes in the cytoplasm. Cotransfection with Htt100Q causes redistribution of WW from the nucleus to the cytoplasm because
of specific interaction of WW and Htt PRR. Cells were stained with FLAG antibody for Htt100Q, HA antibody for WW-NLS, and 4
0,6-diamidino-2-phenylindole for
nuclei. Scale bar, 10 mm.
(B) No colocalization of Htt100Q with PP2WW of HYPB in cytoplasm. PP2WW fused with a C-terminal NLS (PP2WW-NLS) localizes in the nucleus. Cotransfection
with Htt100Q loses the ability to cause redistribution of PP2WW due to weakening of the interaction between WW and Htt PRR by the polyP stretch.
(C) Proportions of the transfected cells with colocalization. Data are from WW-NLS (A) and PP2WW-NLS (B), and data are presented as means ± SEM (n = 30).
(D) Deletion of PRR in Htt100Q (Htt100QDPRR) abolishes colocalization of Htt100Q with WW or PP2WW.
Structure
Intramolecular Regulation of HYPBone. Thus, PP2WW is predominantly in the closed state, effec-
tively inhibiting the WW domain from interacting with other
PRRs, such as Htt PRR (Figure 8), leaving a small fraction of
the open state that has binding ability for other proteins. When
Htt PRR binds to the open state of PP2WW, it may cause the
equilibrium to shift from the closed to the open state. It is also
possible that the state population of the WW domain of HYPB
could be regulated intramolecularly by other PRRs or even by
other proteins or factors. Therefore, elucidating the mechanistic
details of the regulatory interaction between Htt and HYPB is
very important to our understanding of HD, because this specific
interaction is likely to be involved in the disease pathology (Pas-
sani et al., 2000).
Implication in Cellular Regulation and Disease
Pathology
Previous studies revealed that HYPB is associated with the
disease-related deposits of N-terminal Htt (Passani et al.,
2000). Herein we demonstrate that the WW domain in HYPB
can be redistributed from the nucleus to the cytoplasm by inter-
acting with Htt PRR and that the autoinhibitory form of PP2WW384 Structure 22, 378–386, March 4, 2014 ª2014 Elsevier Ltd All righloses the ability to be redistributed by Htt. PolyQ-expanded Htt
can sequester HYPB to the cytoplasm, and thus the biological
function of HYPB might be altered by this regulatory interaction.
HYPB is a H3K36 methyltransferase that is very important for
cellular function (Hu et al., 2010), so it is speculative that HYPB
is relevant to the disease caused by polyQ expansion of Htt.
Therefore, understanding of the molecular mechanism by which
intramolecular interaction of HYPB, as well as how HYPC regu-
lates its binding with polyQ-expanded Htt, will provide implica-
tions for the disease pathology of HD.EXPERIMENTAL PROCEDURES
Proteins and Peptides
The coding sequences of the WW domain (PP12WW, PP2WW, and its
mutants) were amplified by PCR and cloned into the pET-32M plasmid using
the BamHI/XhoI cloning sites. The plasmid was transformed into Escherichia
coli BL21 (DE3) cells. When the cells harboring each plasmid were grown at
37C to an optical density 600 of 0.7, protein expression was induced by
adding isopropyl b-D-1-thiogalactopyranoside. After cell lysis, the supernatant
was loaded onto a nickel-nitrilotriacetic acid column (QIAGEN). After washing
followed by on-column thrombin cleavage to remove the thioredoxin tag, thets reserved
Figure 8. Schematic Representation of the Intramolecular Regula-
tion of the WW domain of HYPB Interacting with Htt
The structure of the WW domain in PP2WW of HYPB between the closed and
open conformational states is in equilibrium. This intramolecular polyP inter-
action with the WW moiety in PP2WW impedes interaction of the oncoming
PRR of the Htt protein, which forms aggregates through b sheet structures by
the expanded polyQ tracts.
Structure
Intramolecular Regulation of HYPBprotein was eluted and subjected to chromatography on a Superdex 75 col-
umn (GE Healthcare). The coding sequence for Htt PRR corresponding to res-
idues 44–78 of Htt was amplified by PCR and cloned into the pGBTNH plasmid
using the BamHI/XhoI cloning sites (Bao et al., 2006). The expression and
purification of Htt-PRR was the same as other proteins described previously,
except that the fused GB1 tag was not removed. 15N- and/or 15N/13C-labeled
proteins were prepared by using M9minimal medium containing 15NH4Cl and/
or 13C6-D-glucose as the sole nitrogen and/or carbon resource, respectively.
The peptides (Pept-1, Pept-2, and Pept-3) were obtained by automatic
solid-phase peptide synthesis as described previously (Gao et al., 2006).
NMR Spectroscopy
To solve the solution structures of WW, PP2WW, and KPP2WW fromHYPB by
NMR, 15N/13C-labeled samples containing 500 mM protein in a phosphate
buffer (20 mM sodium phosphate, 50 mM NaCl, 0.05% w/v sodium azide,
pH 6.5, and 95% H2O/5% D2O or 100% D2O) were used for data acquisition.
All NMR data were recorded at 25C on a Bruker 600-MHz AVANCE III spec-
trometer equipped with a TCI CryoProbe proton-optimized triple resonance
NMR inverse probe (Bruker). The backbone and side-chain 1H, 15N, and 13C
resonances were assigned based on the spectra of 3D HNCO, HNHA,
HNCACB, CBCA(CO)NH, C(CO)NH, and HCCH-TOCSY. NOE distance re-
straints for structure calculations were obtained from 3D 15N-edited and
13C-edited NOESY spectra.
Structure Calculation and Analysis
NMR data processing and structure calculation were performed as reported
previously by investigators at our laboratory (Gao et al., 2006; Jiang et al.,
2011). For WW, PP2WW, and KPP2WW, the restraints used for structure
calculation and statistics are summarized in Table 1. The structural calculation
was performed for nine cycles and a total of two hundred structures were
ultimately obtained. The 15 lowest-energy structures were selected, which ex-Structure 22,hibited no NOE violation >0.3 A˚ and no dihedral violation >5. The structural
graphs were prepared using MOLMOL software (Koradi et al., 1996) or the
UCSF Chimera program (Pettersen et al., 2004).
NMR Titration
NMR titrations of WW and PP2WW with Htt PRR peptides were performed at
25C. 15N-labeled proteins (100 mM) in the above-mentioned NMR buffer were
added in stepwise fashion with Htt PRR peptides to give the peptide/protein
molar ratios, which ranged from 0:1 to 10:1, with each step monitored by
2D 1H-15N HSQC spectra. The combined average chemical shift changes
were calculated as Ddave = [(0.17DdN)
2 + (DdH)
2]1/2, where DdH and DdN are
the chemical shift changes in 1H and 15N dimensions, respectively. The titra-
tion curveswere fitted assuming a bimolecular binding event as described pre-
viously (Chang et al., 2006). The Kd values were obtained by analyzing the
chemical shift changes of three typical residues upon addition of each peptide
following a 1:1 binding mode.
Cell Culture and Immunofluorescence Microscopy
FLAG-tagged Htt100Q (residues 1–171) and Htt100QDPRR (deletion of PRR
segment) were constructed previously (Jiang et al., 2011). WW and PP2WW
fused with an NLS sequence (KRKRR) were cloned into the pcDNA3.0 vector
(with an influenza hemagglutinin (HA) tag). HEK293T cells were transfected
with indicated plasmids using PolyJet reagent (SignaGen Laboratories)
according to the manufacturer’s instructions. The cells were grown on glass
coverslips for 72 hr after transfection. Anti-FLAG (Sigma-Aldrich) and anti-
HA (Santa Cruz Biotechnology) antibodies were used for immunofluorescence
microscopy. The images were obtained using a Leica TCS SP2 confocal
microscope (Leica Microsystems).
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